Sonoma Pharmaceuticals Inc. (SNOA) - Cash per Share

Corporate emblem and logo of Sonoma Pharmaceuticals, Inc. (SNOA)

Logistics disruptions and sanctions are limiting the export of antiseptics from Sonoma Pharmaceuticals (SNOA), causing the cash position per share to exhibit volatility, with the value holding at 0.91. Business stability is supported by AI-controlled robotic filling lines and the implementation of ESG standards in the production of dermatological products to minimize waste.

Sonoma Pharma (SNOA) - Cash Funds per Share from 07/04/2022 to 11/21/2026

Comprehensive metric breakdowns and analytics for Sonoma Pharma (SNOA)

Comprehensive company analysis:Sonoma Pharmaceuticals Inc. - SNOA
Flagship merchandise of Sonoma Pharmaceuticals Inc.

For Sonoma Pharmaceuticals (SNOA), liquidity serves as a key indicator of financial autonomy during business scaling. The cash per share value is determined by dividing the total cash volume by the number of issued securities. Growth in this metric confirms management's ability to fund the Microcyn expansion without incurring new debt. A stable pipeline requires precise capital management to avoid asset stagnation. It is critical for investors to see a balance between the margin of safety and investment efficiency.